Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Immunohistochemical expression of brother of the regulator of imprinted sites (BORIS) in testicular germ cell tumors (CROSBI ID 309946)

Prilog u časopisu | izvorni znanstveni rad | domaća recenzija

Mesić, Ana ; Milošević, Ivana ; Milunović, Vibor ; Milošević, Milan ; Ulamec, Monika ; Krušlin, Božo Immunohistochemical expression of brother of the regulator of imprinted sites (BORIS) in testicular germ cell tumors // Acta medica Croatica, 72 (2018), 455-459

Podaci o odgovornosti

Mesić, Ana ; Milošević, Ivana ; Milunović, Vibor ; Milošević, Milan ; Ulamec, Monika ; Krušlin, Božo

engleski

Immunohistochemical expression of brother of the regulator of imprinted sites (BORIS) in testicular germ cell tumors

Brother of the Regulator of Imprinted Sites (BORIS) has a role in intracellular signalization and is important in epigenetic mechanism control, such as methylation/demethylation of DNA and histones. BORIS may deregulate some tumor suppressor genes. Immunohistochemical expression of BORIS was found in different tumors, some of them showing correlation with poor prognosis. The aim of this study was to determine immunohistochemical expression of BORIS in pure seminomas and different components of testicular mixed germ cell tumors (MGCT). In this study, immunohistochemical expression of BORIS in testicular germ cell tumors (TGCT) was analyzed. Staining intensity and percentage of positive staining cells were used to evaluate the level of expression. Tumor samples from 44 patients were analyzed ; 26 pure seminomas and 18 MGCT. In MGCTs, seminoma component was found in 4, yolk sac in 7, teratoma in 11 and embryonal carcinoma in 13 samples. Expression of BORIS was strong in 80.8% of seminoma cases and in 76.9% of embryonal carcinoma component, 71.4% of yolk sac, 63.6% of teratoma component and 25% of seminomatous component of MGCT. In MGCT, positive correlation was found between BORIS expression in teratomatous component and presence of yolk sac component

BORIS ; testicular germ cell tumors ; immunohistochemistry ; biomarkers

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

72

2018.

455-459

objavljeno

1330-0164

1848-8897

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost